Cargando…
The Intricate Relationship between Type 2 Diabetes Mellitus (T2DM), Insulin Resistance (IR), and Nonalcoholic Fatty Liver Disease (NAFLD)
Nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes mellitus (T2DM) remain as one of the most global problematic metabolic diseases with rapidly increasing prevalence and incidence. Epidemiological studies noted that T2DM patients have by two-fold increase to develop NAFLD, and vice versa....
Autores principales: | Tanase, Daniela Maria, Gosav, Evelina Maria, Costea, Claudia Florida, Ciocoiu, Manuela, Lacatusu, Cristina Mihaela, Maranduca, Minela Aida, Ouatu, Anca, Floria, Mariana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7424491/ https://www.ncbi.nlm.nih.gov/pubmed/32832560 http://dx.doi.org/10.1155/2020/3920196 |
Ejemplares similares
-
Role of Gut Microbiota on Onset and Progression of Microvascular Complications of Type 2 Diabetes (T2DM)
por: Tanase, Daniela Maria, et al.
Publicado: (2020) -
The Predictive Role of the Biomarker Kidney Molecule-1 (KIM-1) in Acute Kidney Injury (AKI) Cisplatin-Induced Nephrotoxicity
por: Tanase, Daniela Maria, et al.
Publicado: (2019) -
Involvement of Ceramides in Non-Alcoholic Fatty Liver Disease (NAFLD) Atherosclerosis (ATS) Development: Mechanisms and Therapeutic Targets
por: Tanase, Daniela Maria, et al.
Publicado: (2021) -
Arterial Hypertension and Interleukins: Potential Therapeutic Target or Future Diagnostic Marker?
por: Tanase, Daniela Maria, et al.
Publicado: (2019) -
Portrayal of NLRP3 Inflammasome in Atherosclerosis: Current Knowledge and Therapeutic Targets
por: Tanase, Daniela Maria, et al.
Publicado: (2023)